Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Diffuse Large B-cell Lymphoma (DLBCL)
100%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
100%
Radiomics
100%
Treatment Outcome Prediction
100%
Area under the Curve
66%
International Prognostic Index
50%
Index Model
33%
Clinical Predictors
33%
Lymphoma Patients
33%
Relapse Risk
33%
Time to Progression
33%
SUVpeak
33%
Metabolic Tumor Volume
33%
Model Evaluation
33%
High Risk
16%
Clinical Features
16%
Logistic Regression
16%
Prediction Model
16%
Newly Diagnosed
16%
Positive Predictive Value
16%
Negative Predictive Value
16%
Outcome Prediction
16%
Receiver Operating Characteristic Curve
16%
Diagnostic Performance
16%
Clinical High Risk
16%
High-risk Population
16%
Standardized Uptake Value
16%
Risk of Progression
16%
Patient-specific
16%
Trial Registration
16%
Prognostic Marker
16%
Large Lesions
16%
Automatic Segmentation
16%
Natural Logarithm
16%
WHO Performance Status
16%
Tumor Metabolism
16%
EudraCT
16%
Accurate Selection
16%
Radiomics Model
16%
Backward Feature Selection
16%
Model Progression
16%
Maximal Distance
16%
Registration number
16%
Treatment Lines
16%
Automated Segmentation Method
16%
Medicine and Dentistry
Polyethylene Terephthalate
100%
Diffuse Large B-Cell Lymphoma
100%
Radiomics
100%
Treatment Outcome
100%
Area under the Curve
57%
Neoplasm
42%
International Prognostic Index
42%
Clinical Predictor
28%
Prevalence
14%
Feature Extraction
14%
High Risk Population
14%
Clinical Feature
14%
Logistic Regression Analysis
14%
Diagnostic Performance
14%
Standardized Uptake Value
14%
Prediction Model
14%
Nursing and Health Professions
Diffuse Large B Cell Lymphoma
100%
Treatment Outcome
100%
Polyethylene Terephthalate
100%
Radiomics
100%
Area under the Curve
57%
International Prognostic Index
42%
Metabolic Tumor Volume
28%
Peak Standardized Uptake Value
28%
Neoplasm
14%
Prevalence
14%
High Risk Population
14%
Clinical Feature
14%
Logistic Regression Analysis
14%
Positive and Negative Predictive Values
14%
Feature Extraction
14%
Standardized Uptake Value
14%
Pharmacology, Toxicology and Pharmaceutical Science
Diffuse Large B Cell Lymphoma
100%
Polyethylene Terephthalate
100%
Neoplasm
100%
Prevalence
33%
Clinical Feature
33%
Immunology and Microbiology
B Cell
100%
Metabolic Tumor Volume
66%
Prevalence
33%
High Risk Population
33%
Feature Extraction
33%